Ronald Ross Watson, PhD, is Professor of Health Promotion Sciences at the University of Arizona, Mel and Enid Zuckerman College of Public Health. Dr. Watson began his research in public health at the Harvard School of Public Health as a Fellow in 1971 doing field work on vaccines in Saudi Arabia. He has done clinical studies in Colombia, Iran, Egypt, Saudi Arabia and the United States which provides a broad international view of public health. He has served in the military reserve hospital for 17 years with extensive training in medical responses to disasters as the chief biochemistry officer of a general hospital, retiring as a Lt. Colonel. He is a distinguished member of several national and international nutrition, immunology, and cancer societies. Dr. Watson’s career has involved studying many lifestyle aspects for their uses in health promotion. He has edited over 100 biomedical reference books and 450 papers and chapters. His teaching and research focuses on alcohol, tobacco, and drugs of abuse in heart function and disease in mouse models. Victor R. Preedy BSc, PhD, DSc, FRSB, FRSPH, FRSC, FRCPath graduated with an Honours Degree in Biology and Physiology with Pharmacology. After gaining his University of London PhD, he received his Membership of the Royal College of Pathologists. He was later awarded his second doctorate (DSc), for his contribution to protein metabolism in health and disease. He is Professor of Clinical Biochemistry (Hon) at King’s College Hospital and Emeritus Professor of Nutritional Biochemistry at King’s College London. He has Honorary Professorships at the University of Hull, and the University of Suffolk. Professor Preedy was the Founding Director and then long-term Director of the Genomics Centre at King’s College London from 2006 to 2020. Professor Preedy has been awarded fellowships of the Royal Society of Biology, the Royal College of Pathologists, the Royal Society for the Promotion of Health, the Royal Institute of Public Health, the Royal Society for Public Health, the Royal Society of Chemistry and the Royal Society of Medicine. He carried out research when attached to the National Heart Hospital (part of Imperial College London), The School of Pharmacy (now part of University College London) and the MRC Centre at Northwick Park Hospital. He has collaborated with international research groups in Finland, Japan, Australia, USA, and Germany. To his credit, Professor Preedy has published over 750 articles, which includes peer-reviewed manuscripts based on original research, abstracts and symposium presentations, reviews and edited books.

"An immediately identified strength of the book is the logical flow of the order of parts, which results in a highly readable book…presents new hypotheses and conclusions on the effects of different bioactive components of prebiotics, probiotics, and synbiotics to prevent diseases and improve the health of various groups of the population." --Acta Alimentaria

• Part 1: Prebiotics in Health Promotion 1. Prebiotics and probiotics: An assessment of their safety and health benefits2. Pre- and Probiotic Supplementation in Ruminant Livestock Production 3. Prebiotic addition in dairy products: processing and health benefits 4. Low lactose Prebiotic-enriched milk 5. Intestinal microbiota in breast-fed infants: insights into infant-associated bifidobacteria and human milk glycans6. Probiotics and Prebiotics for Promoting Health: via Gut Microbiota7. Prebiotics in human milk and in infant formulas 8. Prebiotics and Probiotics in infant nutrition9. Synthesis of Prebiotic Galactooligosaccharides: Science and Technology10. Prebiotics as protectants of lactic acid bacteria 11. Prebiotic agave fructans and immune aspects12. Prebiotic use in children 13. Structural characteristics and prebiotic effects of lotus seed resistant starch Part 2: Probiotics in Food14. Probiotic Lactobacillus strains from Iranian traditional cheeses 15. Safety of Probiotic Bacteria16. Stressors and food environment: towards strategies to improve robustness and stress tolerance in probiotic17. Effect of food composition on probiotic bacteria viability 18. Probiotics and antibiotic use 19. Multistrain Probiotics: the present forward the future20. Production of Probiotic Cultures and Their Incorporation into Foods 21. Prebiotics and Other Microbial Manipulations in Fish Feeds: Prospective Update of Health benefits 22. Current and future applications of bacterial extracellular polysaccharides  23. Probiotic and prebiotic dairy desserts 24. Lactobacillus paracasei-enriched vegetables containing health promoting molecules25. Probiotics from the olive microbiota 26. Kimchi (Korean fermented vegetables) as a probiotic food 27. Probiotics as potential adsorbent of aflatoxin Part 3: Synbiotics: Production, Application, and Health Promotion28. Beta-glucans and synbiotics 29. Probiotics and synbiotics in lactating mothers30. Symbiotics and the immune system 31. Synbiotics and immunization against H9N2 Avian influenza virus32. Probiotics, prebiotics, synbiotics and foodborne illness33. In vitro screening and evaluation of synbiotics 34. Synbiotics and infantile acute gastroenteritis 35. Symbiotics, probiotics and fiber diet in diverticular disease36. Gut Microbiota: Impact of Probiotics, Prebiotics, Synbiotics, Pharmabiotics and Postbiotics on Human Health37. Potential benefits of probiotics, prebiotics, and synbiotic on the intestinal microbiota of the elderly38. Synbiotics in gastrointestinal surgery39. Probiotics, Prebiotics, Synbiotics and other strategies to modulate the gut microbiota in Irritable Bowel Syndrome (IBS)40. Gut microbiota & IBS 41. Synbiotics: a new strategy to improve immune system from gut to the peripheral sites 42. Probiotics and prebiotics for prevention of viral respiratory tract infections43. Synbiotics in the Intensive Care Unit44. Properties of probiotic bacteria: a proteomic approach45. Symbiotic organisms and gut epithelial homeostasis46. Non prebiotic actions of prebioticsPart 4: Probiotics in Health47. Probiotics and physical strength 48. Probiotics in Invasive Candidiasis49. Probiotics and usage in bacterial vaginosis 50. Evidence and rational for probiotics to prevent infections in the elderly51. Probiotics usage in childhood Helicobacter pylori infection 52. Lipoic acid function and its safety in Multiple sclerosis53. Probiotics and health: What publication rate on probiotics, prebiotics and synbiotics implies? 54. The Cholesterol lowering effects of probiotic bacteria on lipid metabolism 55. The Use of Prebiotics, Probiotics, and Synbiotics in the Critically Ill56. Gynecological health and probioticsPart 5: Probiotics and Chronic Diseases57. Probiotics in inflamatory bowel diseases and cancer prevention58. Resistant starch as a bioactive compound in Colorectal Cancer prevention59. Probiotics in cancer prevention, updating the evidence60. Cardiovascular Health and Disease Prevention: Association with Foodborne Pathogens and Potential Benefits ofProbiotics 61. Probiotics usage in heart disease and psychiatry62. Intestinal microbiota and susceptibility to viral infections. Role of probiotics.63. Probiotics and usage in urinary tract infection64. Probiotics: immunomodulatory properties in allergy and eczema65. Prebiotics and Probiotics for the Prevention and Treatment of Food Allergy66. Prebiotics and probiotics for the prevention and treatment of allergic asthma 67. Amelioration of Helicobacter pylori induced PUD by probiotic lactic acid bacteria

Ronald Ross Watson, PhD, is Professor of Health Promotion Sciences at the University of Arizona, Mel and Enid Zuckerman College of Public Health. Dr. Watson began his research in public health at the Harvard School of Public Health as a Fellow in 1971 doing field work on vaccines in Saudi Arabia. He has done clinical studies in Colombia, Iran, Egypt, Saudi Arabia and the United States which provides a broad international view of public health. He has served in the military reserve hospital for 17 years with extensive training in medical responses to disasters as the chief biochemistry officer of a general hospital, retiring as a Lt. Colonel. He is a distinguished member of several national and international nutrition, immunology, and cancer societies. Dr. Watson’s career has involved studying many lifestyle aspects for their uses in health promotion. He has edited over 100 biomedical reference books and 450 papers and chapters. His teaching and research focuses on alcohol, tobacco, and drugs of abuse in heart function and disease in mouse models. Victor R. Preedy BSc, PhD, DSc, FRSB, FRSPH, FRSC, FRCPath graduated with an Honours Degree in Biology and Physiology with Pharmacology. After gaining his University of London PhD, he received his Membership of the Royal College of Pathologists. He was later awarded his second doctorate (DSc), for his contribution to protein metabolism in health and disease. He is Professor of Clinical Biochemistry (Hon) at King’s College Hospital and Emeritus Professor of Nutritional Biochemistry at King’s College London. He has Honorary Professorships at the University of Hull, and the University of Suffolk. Professor Preedy was the Founding Director and then long-term Director of the Genomics Centre at King’s College London from 2006 to 2020. Professor Preedy has been awarded fellowships of the Royal Society of Biology, the Royal College of Pathologists, the Royal Society for the Promotion of Health, the Royal Institute of Public Health, the Royal Society for Public Health, the Royal Society of Chemistry and the Royal Society of Medicine. He carried out research when attached to the National Heart Hospital (part of Imperial College London), The School of Pharmacy (now part of University College London) and the MRC Centre at Northwick Park Hospital. He has collaborated with international research groups in Finland, Japan, Australia, USA, and Germany. To his credit, Professor Preedy has published over 750 articles, which includes peer-reviewed manuscripts based on original research, abstracts and symposium presentations, reviews and edited books.

"An immediately identified strength of the book is the logical flow of the order of parts, which results in a highly readable book…presents new hypotheses and conclusions on the effects of different bioactive components of prebiotics, probiotics, and synbiotics to prevent diseases and improve the health of various groups of the population." --Acta Alimentaria

• Part 1: Prebiotics in Health Promotion 1. Prebiotics and probiotics: An assessment of their safety and health benefits2. Pre- and Probiotic Supplementation in Ruminant Livestock Production 3. Prebiotic addition in dairy products: processing and health benefits 4. Low lactose Prebiotic-enriched milk 5. Intestinal microbiota in breast-fed infants: insights into infant-associated bifidobacteria and human milk glycans6. Probiotics and Prebiotics for Promoting Health: via Gut Microbiota7. Prebiotics in human milk and in infant formulas 8. Prebiotics and Probiotics in infant nutrition9. Synthesis of Prebiotic Galactooligosaccharides: Science and Technology10. Prebiotics as protectants of lactic acid bacteria 11. Prebiotic agave fructans and immune aspects12. Prebiotic use in children 13. Structural characteristics and prebiotic effects of lotus seed resistant starch Part 2: Probiotics in Food14. Probiotic Lactobacillus strains from Iranian traditional cheeses 15. Safety of Probiotic Bacteria16. Stressors and food environment: towards strategies to improve robustness and stress tolerance in probiotic17. Effect of food composition on probiotic bacteria viability 18. Probiotics and antibiotic use 19. Multistrain Probiotics: the present forward the future20. Production of Probiotic Cultures and Their Incorporation into Foods 21. Prebiotics and Other Microbial Manipulations in Fish Feeds: Prospective Update of Health benefits 22. Current and future applications of bacterial extracellular polysaccharides  23. Probiotic and prebiotic dairy desserts 24. Lactobacillus paracasei-enriched vegetables containing health promoting molecules25. Probiotics from the olive microbiota 26. Kimchi (Korean fermented vegetables) as a probiotic food 27. Probiotics as potential adsorbent of aflatoxin Part 3: Synbiotics: Production, Application, and Health Promotion28. Beta-glucans and synbiotics 29. Probiotics and synbiotics in lactating mothers30. Symbiotics and the immune system 31. Synbiotics and immunization against H9N2 Avian influenza virus32. Probiotics, prebiotics, synbiotics and foodborne illness33. In vitro screening and evaluation of synbiotics 34. Synbiotics and infantile acute gastroenteritis 35. Symbiotics, probiotics and fiber diet in diverticular disease36. Gut Microbiota: Impact of Probiotics, Prebiotics, Synbiotics, Pharmabiotics and Postbiotics on Human Health37. Potential benefits of probiotics, prebiotics, and synbiotic on the intestinal microbiota of the elderly38. Synbiotics in gastrointestinal surgery39. Probiotics, Prebiotics, Synbiotics and other strategies to modulate the gut microbiota in Irritable Bowel Syndrome (IBS)40. Gut microbiota & IBS 41. Synbiotics: a new strategy to improve immune system from gut to the peripheral sites 42. Probiotics and prebiotics for prevention of viral respiratory tract infections43. Synbiotics in the Intensive Care Unit44. Properties of probiotic bacteria: a proteomic approach45. Symbiotic organisms and gut epithelial homeostasis46. Non prebiotic actions of prebioticsPart 4: Probiotics in Health47. Probiotics and physical strength 48. Probiotics in Invasive Candidiasis49. Probiotics and usage in bacterial vaginosis 50. Evidence and rational for probiotics to prevent infections in the elderly51. Probiotics usage in childhood Helicobacter pylori infection 52. Lipoic acid function and its safety in Multiple sclerosis53. Probiotics and health: What publication rate on probiotics, prebiotics and synbiotics implies? 54. The Cholesterol lowering effects of probiotic bacteria on lipid metabolism 55. The Use of Prebiotics, Probiotics, and Synbiotics in the Critically Ill56. Gynecological health and probioticsPart 5: Probiotics and Chronic Diseases57. Probiotics in inflamatory bowel diseases and cancer prevention58. Resistant starch as a bioactive compound in Colorectal Cancer prevention59. Probiotics in cancer prevention, updating the evidence60. Cardiovascular Health and Disease Prevention: Association with Foodborne Pathogens and Potential Benefits ofProbiotics 61. Probiotics usage in heart disease and psychiatry62. Intestinal microbiota and susceptibility to viral infections. Role of probiotics.63. Probiotics and usage in urinary tract infection64. Probiotics: immunomodulatory properties in allergy and eczema65. Prebiotics and Probiotics for the Prevention and Treatment of Food Allergy66. Prebiotics and probiotics for the prevention and treatment of allergic asthma 67. Amelioration of Helicobacter pylori induced PUD by probiotic lactic acid bacteria

Ronald Ross Watson, PhD, is Professor of Health Promotion Sciences at the University of Arizona, Mel and Enid Zuckerman College of Public Health. Dr. Watson began his research in public health at the Harvard School of Public Health as a Fellow in 1971 doing field work on vaccines in Saudi Arabia. He has done clinical studies in Colombia, Iran, Egypt, Saudi Arabia and the United States which provides a broad international view of public health. He has served in the military reserve hospital for 17 years with extensive training in medical responses to disasters as the chief biochemistry officer of a general hospital, retiring as a Lt. Colonel. He is a distinguished member of several national and international nutrition, immunology, and cancer societies. Dr. Watson’s career has involved studying many lifestyle aspects for their uses in health promotion. He has edited over 100 biomedical reference books and 450 papers and chapters. His teaching and research focuses on alcohol, tobacco, and drugs of abuse in heart function and disease in mouse models. Victor R. Preedy BSc, PhD, DSc, FRSB, FRSPH, FRSC, FRCPath graduated with an Honours Degree in Biology and Physiology with Pharmacology. After gaining his University of London PhD, he received his Membership of the Royal College of Pathologists. He was later awarded his second doctorate (DSc), for his contribution to protein metabolism in health and disease. He is Professor of Clinical Biochemistry (Hon) at King’s College Hospital and Emeritus Professor of Nutritional Biochemistry at King’s College London. He has Honorary Professorships at the University of Hull, and the University of Suffolk. Professor Preedy was the Founding Director and then long-term Director of the Genomics Centre at King’s College London from 2006 to 2020. Professor Preedy has been awarded fellowships of the Royal Society of Biology, the Royal College of Pathologists, the Royal Society for the Promotion of Health, the Royal Institute of Public Health, the Royal Society for Public Health, the Royal Society of Chemistry and the Royal Society of Medicine. He carried out research when attached to the National Heart Hospital (part of Imperial College London), The School of Pharmacy (now part of University College London) and the MRC Centre at Northwick Park Hospital. He has collaborated with international research groups in Finland, Japan, Australia, USA, and Germany. To his credit, Professor Preedy has published over 750 articles, which includes peer-reviewed manuscripts based on original research, abstracts and symposium presentations, reviews and edited books.

"An immediately identified strength of the book is the logical flow of the order of parts, which results in a highly readable book…presents new hypotheses and conclusions on the effects of different bioactive components of prebiotics, probiotics, and synbiotics to prevent diseases and improve the health of various groups of the population." --Acta Alimentaria

• Part 1: Prebiotics in Health Promotion 1. Prebiotics and probiotics: An assessment of their safety and health benefits2. Pre- and Probiotic Supplementation in Ruminant Livestock Production 3. Prebiotic addition in dairy products: processing and health benefits 4. Low lactose Prebiotic-enriched milk 5. Intestinal microbiota in breast-fed infants: insights into infant-associated bifidobacteria and human milk glycans6. Probiotics and Prebiotics for Promoting Health: via Gut Microbiota7. Prebiotics in human milk and in infant formulas 8. Prebiotics and Probiotics in infant nutrition9. Synthesis of Prebiotic Galactooligosaccharides: Science and Technology10. Prebiotics as protectants of lactic acid bacteria 11. Prebiotic agave fructans and immune aspects12. Prebiotic use in children 13. Structural characteristics and prebiotic effects of lotus seed resistant starch Part 2: Probiotics in Food14. Probiotic Lactobacillus strains from Iranian traditional cheeses 15. Safety of Probiotic Bacteria16. Stressors and food environment: towards strategies to improve robustness and stress tolerance in probiotic17. Effect of food composition on probiotic bacteria viability 18. Probiotics and antibiotic use 19. Multistrain Probiotics: the present forward the future20. Production of Probiotic Cultures and Their Incorporation into Foods 21. Prebiotics and Other Microbial Manipulations in Fish Feeds: Prospective Update of Health benefits 22. Current and future applications of bacterial extracellular polysaccharides  23. Probiotic and prebiotic dairy desserts 24. Lactobacillus paracasei-enriched vegetables containing health promoting molecules25. Probiotics from the olive microbiota 26. Kimchi (Korean fermented vegetables) as a probiotic food 27. Probiotics as potential adsorbent of aflatoxin Part 3: Synbiotics: Production, Application, and Health Promotion28. Beta-glucans and synbiotics 29. Probiotics and synbiotics in lactating mothers30. Symbiotics and the immune system 31. Synbiotics and immunization against H9N2 Avian influenza virus32. Probiotics, prebiotics, synbiotics and foodborne illness33. In vitro screening and evaluation of synbiotics 34. Synbiotics and infantile acute gastroenteritis 35. Symbiotics, probiotics and fiber diet in diverticular disease36. Gut Microbiota: Impact of Probiotics, Prebiotics, Synbiotics, Pharmabiotics and Postbiotics on Human Health37. Potential benefits of probiotics, prebiotics, and synbiotic on the intestinal microbiota of the elderly38. Synbiotics in gastrointestinal surgery39. Probiotics, Prebiotics, Synbiotics and other strategies to modulate the gut microbiota in Irritable Bowel Syndrome (IBS)40. Gut microbiota & IBS 41. Synbiotics: a new strategy to improve immune system from gut to the peripheral sites 42. Probiotics and prebiotics for prevention of viral respiratory tract infections43. Synbiotics in the Intensive Care Unit44. Properties of probiotic bacteria: a proteomic approach45. Symbiotic organisms and gut epithelial homeostasis46. Non prebiotic actions of prebioticsPart 4: Probiotics in Health47. Probiotics and physical strength 48. Probiotics in Invasive Candidiasis49. Probiotics and usage in bacterial vaginosis 50. Evidence and rational for probiotics to prevent infections in the elderly51. Probiotics usage in childhood Helicobacter pylori infection 52. Lipoic acid function and its safety in Multiple sclerosis53. Probiotics and health: What publication rate on probiotics, prebiotics and synbiotics implies? 54. The Cholesterol lowering effects of probiotic bacteria on lipid metabolism 55. The Use of Prebiotics, Probiotics, and Synbiotics in the Critically Ill56. Gynecological health and probioticsPart 5: Probiotics and Chronic Diseases57. Probiotics in inflamatory bowel diseases and cancer prevention58. Resistant starch as a bioactive compound in Colorectal Cancer prevention59. Probiotics in cancer prevention, updating the evidence60. Cardiovascular Health and Disease Prevention: Association with Foodborne Pathogens and Potential Benefits ofProbiotics 61. Probiotics usage in heart disease and psychiatry62. Intestinal microbiota and susceptibility to viral infections. Role of probiotics.63. Probiotics and usage in urinary tract infection64. Probiotics: immunomodulatory properties in allergy and eczema65. Prebiotics and Probiotics for the Prevention and Treatment of Food Allergy66. Prebiotics and probiotics for the prevention and treatment of allergic asthma 67. Amelioration of Helicobacter pylori induced PUD by probiotic lactic acid bacteria